101
|
Verzaux S, Notredame C, Pauwels N, Danel T, Vaiva G, Walter M. Validation d’une grille d’évaluation qualitative d’articles de presse écrite sur le suicide, dans le cadre du programme Papageno. Eur Psychiatry 2015. [DOI: 10.1016/j.eurpsy.2015.09.285] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
ContexteLa couverture médiatique d’un fait suicidaire influence le taux de suicide par le biais d’un effet d’incitation, aussi nommé « effet Werther » (EW) ou d’un potentiel rôle préventif via « l’effet Papageno » (EP) . L’objectif du programme national français Papageno est d’améliorer les propriétés qualitatives du contenu médiatique dont dépendent principalement l’EW et l’EP, via l’application des recommandations de l’Organisation mondiale de la Santé (OMS) pour un traitement journalistique plus responsable du suicide. L’évaluation de l’efficacité du programme est donc un enjeu de prévention qui nécessite un outil d’analyse fidèle à ces recommandations.ObjectifsÉlaborer et valider une grille d’analyse qualitative permettant, pour chaque article de presse traitant du suicide, de mesurer le degré de compliance aux recommandations de l’OMS et de quantifier le risque d’EW et le potentiel EP.MéthodeLa grille d’évaluation PReSS (Print media Reporting on Suicide Scale) combine 10 items descriptifs et 19 items qualitatifs issus de l’opérationnalisation des 11 recommandations de l’OMS. La validation de la fiabilité interjuges a été obtenue par séries de double cotation-correction de 25 articles traitant du suicide. Les critères de satisfaction des items ont été affinés après chaque série jusqu’à obtention d’un coefficient de kappa ≥ 0.7 pour chacun. À titre d’illustration, le traitement médiatique du supposé suicide du pilote d’avion A. Lubitz en mars 2015 a été analysé grâce à la PReSS.RésultatsTrois séries de cotation-correction ont été nécessaires pour valider la grille. L’analyse de la couverture du suicide présumé d’A. Lubitz montre un compliance faible aux recommandations, un score Papageno bas et un score Werther élevé.ConclusionLa grille d’évaluation PReSS est un outil fiable et utile pour mesurer la compliance aux recommandations de l’OMS concernant la couverture médiatique du suicide.
Collapse
|
102
|
Gourgari E, Lodish M, Shamburek R, Keil M, Wesley R, Walter M, Sampson M, Bernstein S, Khurana D, Lyssikatos C, Ten S, Dobs A, Remaley AT, Stratakis CA. Lipoprotein Particles in Adolescents and Young Women With PCOS Provide Insights Into Their Cardiovascular Risk. J Clin Endocrinol Metab 2015; 100:4291-8. [PMID: 26371381 PMCID: PMC4702461 DOI: 10.1210/jc.2015-2566] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
CONTEXT Adult women with polycystic ovarian syndrome (PCOS) have an increased risk for cardiovascular disease, but the evidence for this is controversial in adolescents and young women with PCOS. Measurement of low-density lipoprotein (LDL) particle number, measured by nuclear magnetic resonance spectroscopy is a novel technology to assess cardiovascular risk. OBJECTIVE The objective of the study was to evaluate lipoprotein particle number and size in young women with PCOS and its relationship with insulin resistance and hyperandrogenism. DESIGN This was a cross-sectional case control study. SETTING The study was conducted at a clinical research center. PARTICIPANTS Women with PCOS (n = 35) and normal controls (n = 20) participated in the study. INTERVENTIONS Blood samples and anthropometric measures were obtained. MAIN OUTCOME MEASURES LDL particle size and number were measured using nuclear magnetic resonance spectroscopy. A secondary outcome was to investigate the correlation of LDL particle number with high-sensitivity C-reactive protein, waist to hip ratio, hyperandrogenism, insulin resistance, and adiponectin. RESULTS Women with PCOS had higher LDL particle number when compared with healthy controls (935 ± 412 vs 735 ± 264, P = .032); LDL particle number correlated strongly with high-sensitivity C-reactive protein (r = 0.37, P = .006) and waist-to-hip (r = 0.57, P = .0003). The higher LDL particle number was driven mainly due to differences in the small LDL particle number (sLDLp), with PCOS patients having more sLDLp (348 ± 305 vs 178 ± 195, P = .015). The sLDLp correlated with the Matsuda index (r = -0.51, P = .0001), homeostasis model assessment index of insulin resistance (r = 0.41, P = .002), and adiponectin (r = -0.46, P = .0004) but not with T. CONCLUSION Adolescent and young women with PCOS have an atherogenic lipoprotein profile suggestive of increased cardiovascular risk that appears to be driven by the degree of visceral adiposity and insulin resistance.
Collapse
Affiliation(s)
- E Gourgari
- Section on Endocrinology and Genetics (E.G., M.L., M.K., S.B., C.L., C.A.S.), Program on Developmental Endocrinology and Genetics and Pediatric Endocrinology Inter-Institute Training Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and Section of Clinical Laboratory Services (M.W.), National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, Maryland 20892; Division of Pediatric Endocrinology (E.G.), Georgetown University Medical Center, Washington, DC 20057; Section of Lipoprotein Metabolism (R.S., A.T.R., M.S.), National Heart, Lung, and Blood Institute, Bethesda, Maryland 20824; Biostatistics and Clinical Epidemiology Service (R.W.), National Institutes of Health Clinical Center, Bethesda, Maryland 20814; Division of Pediatric Endocrinology (M.W.), Infants and Children's Hospital of Brooklyn at Maimonides and Children and Hospital at Downstate, State University of New York, Brooklyn, New York 11219; and Department of Endocrinology (D.K., S.T., A.D.), Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
| | - M Lodish
- Section on Endocrinology and Genetics (E.G., M.L., M.K., S.B., C.L., C.A.S.), Program on Developmental Endocrinology and Genetics and Pediatric Endocrinology Inter-Institute Training Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and Section of Clinical Laboratory Services (M.W.), National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, Maryland 20892; Division of Pediatric Endocrinology (E.G.), Georgetown University Medical Center, Washington, DC 20057; Section of Lipoprotein Metabolism (R.S., A.T.R., M.S.), National Heart, Lung, and Blood Institute, Bethesda, Maryland 20824; Biostatistics and Clinical Epidemiology Service (R.W.), National Institutes of Health Clinical Center, Bethesda, Maryland 20814; Division of Pediatric Endocrinology (M.W.), Infants and Children's Hospital of Brooklyn at Maimonides and Children and Hospital at Downstate, State University of New York, Brooklyn, New York 11219; and Department of Endocrinology (D.K., S.T., A.D.), Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
| | - R Shamburek
- Section on Endocrinology and Genetics (E.G., M.L., M.K., S.B., C.L., C.A.S.), Program on Developmental Endocrinology and Genetics and Pediatric Endocrinology Inter-Institute Training Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and Section of Clinical Laboratory Services (M.W.), National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, Maryland 20892; Division of Pediatric Endocrinology (E.G.), Georgetown University Medical Center, Washington, DC 20057; Section of Lipoprotein Metabolism (R.S., A.T.R., M.S.), National Heart, Lung, and Blood Institute, Bethesda, Maryland 20824; Biostatistics and Clinical Epidemiology Service (R.W.), National Institutes of Health Clinical Center, Bethesda, Maryland 20814; Division of Pediatric Endocrinology (M.W.), Infants and Children's Hospital of Brooklyn at Maimonides and Children and Hospital at Downstate, State University of New York, Brooklyn, New York 11219; and Department of Endocrinology (D.K., S.T., A.D.), Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
| | - M Keil
- Section on Endocrinology and Genetics (E.G., M.L., M.K., S.B., C.L., C.A.S.), Program on Developmental Endocrinology and Genetics and Pediatric Endocrinology Inter-Institute Training Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and Section of Clinical Laboratory Services (M.W.), National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, Maryland 20892; Division of Pediatric Endocrinology (E.G.), Georgetown University Medical Center, Washington, DC 20057; Section of Lipoprotein Metabolism (R.S., A.T.R., M.S.), National Heart, Lung, and Blood Institute, Bethesda, Maryland 20824; Biostatistics and Clinical Epidemiology Service (R.W.), National Institutes of Health Clinical Center, Bethesda, Maryland 20814; Division of Pediatric Endocrinology (M.W.), Infants and Children's Hospital of Brooklyn at Maimonides and Children and Hospital at Downstate, State University of New York, Brooklyn, New York 11219; and Department of Endocrinology (D.K., S.T., A.D.), Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
| | - R Wesley
- Section on Endocrinology and Genetics (E.G., M.L., M.K., S.B., C.L., C.A.S.), Program on Developmental Endocrinology and Genetics and Pediatric Endocrinology Inter-Institute Training Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and Section of Clinical Laboratory Services (M.W.), National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, Maryland 20892; Division of Pediatric Endocrinology (E.G.), Georgetown University Medical Center, Washington, DC 20057; Section of Lipoprotein Metabolism (R.S., A.T.R., M.S.), National Heart, Lung, and Blood Institute, Bethesda, Maryland 20824; Biostatistics and Clinical Epidemiology Service (R.W.), National Institutes of Health Clinical Center, Bethesda, Maryland 20814; Division of Pediatric Endocrinology (M.W.), Infants and Children's Hospital of Brooklyn at Maimonides and Children and Hospital at Downstate, State University of New York, Brooklyn, New York 11219; and Department of Endocrinology (D.K., S.T., A.D.), Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
| | - M Walter
- Section on Endocrinology and Genetics (E.G., M.L., M.K., S.B., C.L., C.A.S.), Program on Developmental Endocrinology and Genetics and Pediatric Endocrinology Inter-Institute Training Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and Section of Clinical Laboratory Services (M.W.), National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, Maryland 20892; Division of Pediatric Endocrinology (E.G.), Georgetown University Medical Center, Washington, DC 20057; Section of Lipoprotein Metabolism (R.S., A.T.R., M.S.), National Heart, Lung, and Blood Institute, Bethesda, Maryland 20824; Biostatistics and Clinical Epidemiology Service (R.W.), National Institutes of Health Clinical Center, Bethesda, Maryland 20814; Division of Pediatric Endocrinology (M.W.), Infants and Children's Hospital of Brooklyn at Maimonides and Children and Hospital at Downstate, State University of New York, Brooklyn, New York 11219; and Department of Endocrinology (D.K., S.T., A.D.), Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
| | - M Sampson
- Section on Endocrinology and Genetics (E.G., M.L., M.K., S.B., C.L., C.A.S.), Program on Developmental Endocrinology and Genetics and Pediatric Endocrinology Inter-Institute Training Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and Section of Clinical Laboratory Services (M.W.), National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, Maryland 20892; Division of Pediatric Endocrinology (E.G.), Georgetown University Medical Center, Washington, DC 20057; Section of Lipoprotein Metabolism (R.S., A.T.R., M.S.), National Heart, Lung, and Blood Institute, Bethesda, Maryland 20824; Biostatistics and Clinical Epidemiology Service (R.W.), National Institutes of Health Clinical Center, Bethesda, Maryland 20814; Division of Pediatric Endocrinology (M.W.), Infants and Children's Hospital of Brooklyn at Maimonides and Children and Hospital at Downstate, State University of New York, Brooklyn, New York 11219; and Department of Endocrinology (D.K., S.T., A.D.), Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
| | - S Bernstein
- Section on Endocrinology and Genetics (E.G., M.L., M.K., S.B., C.L., C.A.S.), Program on Developmental Endocrinology and Genetics and Pediatric Endocrinology Inter-Institute Training Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and Section of Clinical Laboratory Services (M.W.), National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, Maryland 20892; Division of Pediatric Endocrinology (E.G.), Georgetown University Medical Center, Washington, DC 20057; Section of Lipoprotein Metabolism (R.S., A.T.R., M.S.), National Heart, Lung, and Blood Institute, Bethesda, Maryland 20824; Biostatistics and Clinical Epidemiology Service (R.W.), National Institutes of Health Clinical Center, Bethesda, Maryland 20814; Division of Pediatric Endocrinology (M.W.), Infants and Children's Hospital of Brooklyn at Maimonides and Children and Hospital at Downstate, State University of New York, Brooklyn, New York 11219; and Department of Endocrinology (D.K., S.T., A.D.), Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
| | - D Khurana
- Section on Endocrinology and Genetics (E.G., M.L., M.K., S.B., C.L., C.A.S.), Program on Developmental Endocrinology and Genetics and Pediatric Endocrinology Inter-Institute Training Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and Section of Clinical Laboratory Services (M.W.), National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, Maryland 20892; Division of Pediatric Endocrinology (E.G.), Georgetown University Medical Center, Washington, DC 20057; Section of Lipoprotein Metabolism (R.S., A.T.R., M.S.), National Heart, Lung, and Blood Institute, Bethesda, Maryland 20824; Biostatistics and Clinical Epidemiology Service (R.W.), National Institutes of Health Clinical Center, Bethesda, Maryland 20814; Division of Pediatric Endocrinology (M.W.), Infants and Children's Hospital of Brooklyn at Maimonides and Children and Hospital at Downstate, State University of New York, Brooklyn, New York 11219; and Department of Endocrinology (D.K., S.T., A.D.), Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
| | - C Lyssikatos
- Section on Endocrinology and Genetics (E.G., M.L., M.K., S.B., C.L., C.A.S.), Program on Developmental Endocrinology and Genetics and Pediatric Endocrinology Inter-Institute Training Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and Section of Clinical Laboratory Services (M.W.), National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, Maryland 20892; Division of Pediatric Endocrinology (E.G.), Georgetown University Medical Center, Washington, DC 20057; Section of Lipoprotein Metabolism (R.S., A.T.R., M.S.), National Heart, Lung, and Blood Institute, Bethesda, Maryland 20824; Biostatistics and Clinical Epidemiology Service (R.W.), National Institutes of Health Clinical Center, Bethesda, Maryland 20814; Division of Pediatric Endocrinology (M.W.), Infants and Children's Hospital of Brooklyn at Maimonides and Children and Hospital at Downstate, State University of New York, Brooklyn, New York 11219; and Department of Endocrinology (D.K., S.T., A.D.), Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
| | - S Ten
- Section on Endocrinology and Genetics (E.G., M.L., M.K., S.B., C.L., C.A.S.), Program on Developmental Endocrinology and Genetics and Pediatric Endocrinology Inter-Institute Training Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and Section of Clinical Laboratory Services (M.W.), National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, Maryland 20892; Division of Pediatric Endocrinology (E.G.), Georgetown University Medical Center, Washington, DC 20057; Section of Lipoprotein Metabolism (R.S., A.T.R., M.S.), National Heart, Lung, and Blood Institute, Bethesda, Maryland 20824; Biostatistics and Clinical Epidemiology Service (R.W.), National Institutes of Health Clinical Center, Bethesda, Maryland 20814; Division of Pediatric Endocrinology (M.W.), Infants and Children's Hospital of Brooklyn at Maimonides and Children and Hospital at Downstate, State University of New York, Brooklyn, New York 11219; and Department of Endocrinology (D.K., S.T., A.D.), Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
| | - A Dobs
- Section on Endocrinology and Genetics (E.G., M.L., M.K., S.B., C.L., C.A.S.), Program on Developmental Endocrinology and Genetics and Pediatric Endocrinology Inter-Institute Training Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and Section of Clinical Laboratory Services (M.W.), National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, Maryland 20892; Division of Pediatric Endocrinology (E.G.), Georgetown University Medical Center, Washington, DC 20057; Section of Lipoprotein Metabolism (R.S., A.T.R., M.S.), National Heart, Lung, and Blood Institute, Bethesda, Maryland 20824; Biostatistics and Clinical Epidemiology Service (R.W.), National Institutes of Health Clinical Center, Bethesda, Maryland 20814; Division of Pediatric Endocrinology (M.W.), Infants and Children's Hospital of Brooklyn at Maimonides and Children and Hospital at Downstate, State University of New York, Brooklyn, New York 11219; and Department of Endocrinology (D.K., S.T., A.D.), Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
| | - A T Remaley
- Section on Endocrinology and Genetics (E.G., M.L., M.K., S.B., C.L., C.A.S.), Program on Developmental Endocrinology and Genetics and Pediatric Endocrinology Inter-Institute Training Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and Section of Clinical Laboratory Services (M.W.), National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, Maryland 20892; Division of Pediatric Endocrinology (E.G.), Georgetown University Medical Center, Washington, DC 20057; Section of Lipoprotein Metabolism (R.S., A.T.R., M.S.), National Heart, Lung, and Blood Institute, Bethesda, Maryland 20824; Biostatistics and Clinical Epidemiology Service (R.W.), National Institutes of Health Clinical Center, Bethesda, Maryland 20814; Division of Pediatric Endocrinology (M.W.), Infants and Children's Hospital of Brooklyn at Maimonides and Children and Hospital at Downstate, State University of New York, Brooklyn, New York 11219; and Department of Endocrinology (D.K., S.T., A.D.), Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
| | - C A Stratakis
- Section on Endocrinology and Genetics (E.G., M.L., M.K., S.B., C.L., C.A.S.), Program on Developmental Endocrinology and Genetics and Pediatric Endocrinology Inter-Institute Training Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and Section of Clinical Laboratory Services (M.W.), National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, Maryland 20892; Division of Pediatric Endocrinology (E.G.), Georgetown University Medical Center, Washington, DC 20057; Section of Lipoprotein Metabolism (R.S., A.T.R., M.S.), National Heart, Lung, and Blood Institute, Bethesda, Maryland 20824; Biostatistics and Clinical Epidemiology Service (R.W.), National Institutes of Health Clinical Center, Bethesda, Maryland 20814; Division of Pediatric Endocrinology (M.W.), Infants and Children's Hospital of Brooklyn at Maimonides and Children and Hospital at Downstate, State University of New York, Brooklyn, New York 11219; and Department of Endocrinology (D.K., S.T., A.D.), Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
| |
Collapse
|
103
|
Berrouiguet S, Alavi Z, Vaiva G, Courtet P, Baca Garcia E, Vidailhet P, Gravet M, Guillodo E, Brandt S, Walter M. Développement d’un dispositif de veille par short message service (SMS) pour la prévention de la récidive suicidaire. Protocole d’étude Suicide Intervention Assisted by Messages (SIAM). Eur Psychiatry 2015. [DOI: 10.1016/j.eurpsy.2015.09.042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
Abstract
IntroductionLe suicide et les conduites auto-agressives sont fréquents dans la population adulte. De précédentes études ont prouvé que le fait de maintenir le lien avec le sujet suicidant, par lettres ou cartes postales, après la prise en charge en aigu, réduit le risque de récidive. De plus, les études de faisabilité ont montré que l’intervention par SMS est acceptable pour les patients. L‘objectif principal de cette étude est de démontrer l’efficacité du dispositif de veille par SMS sur la réduction de la récidive suicidaire à 6 mois. Nous présenterons dans un premier temps l’étude de faisabilité puis l’étude multicentrique démarrée dans 8 CHU.Matériel et méthodeIl s’agira d’un essai de supériorité, contrôlé, randomisé, multicentrique, d’une durée de 2 ans, et piloté par le CHRU de Brest. Les sujets seront des adultes ayant survécu à un passage à l’acte suicidaire, inclus après une prise en charge aux urgences ou une courte hospitalisation. Le recrutement s’étalera sur une période de 9 mois. Les SMS seront envoyés à j2, j7, j15, puis mensuellement. Ces messages se soucieront du bien-être du patient, et lui rappelleront les coordonnées d’urgence dont il dispose en cas de besoin. Les patients seront évalués à j0, puis à 6 et 13 mois. Le critère de jugement principal sera le nombre de patients récidivant à 6 mois, dans le groupe recevant les SMS et dans le groupe témoin (qui bénéficie de la prise en charge de référence). Les critères de jugement secondaires seront le nombre de patients récidivant à 13 mois, le nombre de tentatives de suicide à 6 et 13 mois, le nombre de décès par suicide à 6 et 13 mois, dans les deux groupes. Les idées suicidaires seront évaluées dans chaque groupe, à j0, à 6 mois, et à 13 mois. Enfin, les coûts médicaux et la satisfaction seront évalués à 13 mois.Résultats attendusLa fréquence de récidive attendue à 6 mois dans le groupe témoin est de l’ordre de 18 %. Nous espérons la réduire à 9 % grâce au contact par SMS. Afin d’y parvenir, le nombre de sujets nécessaires a été évalué à 530, soit 265 dans chaque bras.DiscussionCe dispositif de veille par SMS s’appuie sur de précédentes interventions, aux résultats significatifs dans le domaine, et est facilement reproductible. Nous proposons d’évaluer son efficacité dans la réduction du risque de récidive suicidaire au sein d’une population d’adultes ayant fait un passage à l’acte.
Collapse
|
104
|
Abstract
L’accès aux soins des personnes à risque constitue un pilier essentiel de la prévention du suicide. Cependant, les idées reçues véhiculées autour des conduites suicidaires y opposent un obstacle significatif. Afin de cibler au mieux les campagnes d’information qui dissiperaient ces mythes, et pour en évaluer l’efficacité, les connaissances sur le suicide devraient pouvoir être quantifiées de façon fiable. À ce jour, seules quelques études anglo-saxonnes dédiées ont été validées. La limite décisive à leur interprétation tient cependant à ce qu’elles ne permettent pas d’approche normative. En effet, l’exactitude de leurs propositions n’est validée par aucun étalon officiel, alors même que certaines relèvent plus de l’expérience clinique que de connaissances issues de la littérature. Notre objectif consiste à palier cette limite en proposant une échelle dont la cotation est adaptée à l’évaluation d’un savoir normé. Le Questionnaire d’Évaluation des Connaissances sur le Suicide (QECS) est un auto-questionnaire qui explore, en 35 items, les principales connaissances relatives à l’épidémiologie et aux mythes communs concernant le suicide. Les réponses y sont recueillies par échelle visuelle analogique. La cotation finale se fait en confrontant ces réponses à celles d’un panel de référence constitué de spécialistes en suicidologie (n = 47). Nous présentons ici les résultats de ce panel, ainsi qu’une illustration des potentialités d’interprétation du QECS, via l’évaluation des connaissances d’un échantillon test d’étudiants en journalisme (n = 111). Les réponses du panel de référence étaient significativement différentes de « ni accord, ni désaccord » pour 27 des 29 items dédiés aux mythes. Pour 25 de ces items, une différence significative était retrouvée entre l’échantillon test et le panel de référence. Ainsi attestée, l’existence d’un avis expertal spécifique a servi d’étalon pour 2 modes de cotation des réponses de l’échantillon test : un score de véracité et un score de concordance aux experts.
Collapse
|
105
|
Park F, Russo K, Williams P, Pelosi M, Puddephatt R, Walter M, Leung C, Saaid R, Rawashdeh H, Ogle R, Hyett J. Prediction and prevention of early-onset pre-eclampsia: impact of aspirin after first-trimester screening. Ultrasound Obstet Gynecol 2015; 46:419-423. [PMID: 25678383 DOI: 10.1002/uog.14819] [Citation(s) in RCA: 56] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/13/2014] [Revised: 01/30/2015] [Accepted: 01/30/2015] [Indexed: 06/04/2023]
Abstract
OBJECTIVE To examine the effect of a combination of screening and treatment with low-dose aspirin on the prevalence of early-onset pre-eclampsia (PE). METHODS This was a retrospective analysis of two consecutive cohorts of women screened for early PE. The first cohort was observed to determine whether algorithms developed to screen for PE at 11 to 13 + 6 weeks' gestation could be applied to our population. High-risk women in the second cohort were advised on their risk and offered aspirin (150 mg at night), with treatment starting immediately after screening. The prevalence of early PE and the proportion of women with PE delivering at 34-37 weeks' gestation were compared between the cohorts. RESULTS In the observational and interventional cohorts, 3066 and 2717 women, respectively, were screened. There were 12 (0.4%) cases of early PE in the observational cohort and one (0.04%) in the interventional cohort (P < 0.01). Among all women with PE delivering before 37 weeks, 25 (0.83%) were in the observational cohort and 10 (0.37%) in the interventional cohort (P = 0.03). CONCLUSIONS A strategy of first-trimester screening for early PE coupled with prescription of aspirin to the high-risk group appears to be effective in reducing the prevalence of early PE.
Collapse
Affiliation(s)
- F Park
- Central Clinical School, Faculty of Medicine, University of Sydney, Sydney, NSW, Australia
- RPA Women and Babies, Royal Prince Alfred Hospital, Sydney, NSW, Australia
| | - K Russo
- Central Clinical School, Faculty of Medicine, University of Sydney, Sydney, NSW, Australia
| | - P Williams
- Central Clinical School, Faculty of Medicine, University of Sydney, Sydney, NSW, Australia
- Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, NSW, Australia
| | - M Pelosi
- RPA Women and Babies, Royal Prince Alfred Hospital, Sydney, NSW, Australia
| | - R Puddephatt
- RPA Women and Babies, Royal Prince Alfred Hospital, Sydney, NSW, Australia
| | - M Walter
- RPA Women and Babies, Royal Prince Alfred Hospital, Sydney, NSW, Australia
| | - C Leung
- Central Clinical School, Faculty of Medicine, University of Sydney, Sydney, NSW, Australia
| | - R Saaid
- RPA Women and Babies, Royal Prince Alfred Hospital, Sydney, NSW, Australia
- Department of Obstetrics and Gynaecology, University of Malaya, Kuala Lumpur, Malaysia
| | - H Rawashdeh
- RPA Women and Babies, Royal Prince Alfred Hospital, Sydney, NSW, Australia
| | - R Ogle
- RPA Women and Babies, Royal Prince Alfred Hospital, Sydney, NSW, Australia
| | - J Hyett
- Central Clinical School, Faculty of Medicine, University of Sydney, Sydney, NSW, Australia
- RPA Women and Babies, Royal Prince Alfred Hospital, Sydney, NSW, Australia
| |
Collapse
|
106
|
Colic L, Demenescu LR, Li M, Kaufmann J, Krause AL, Metzger C, Walter M. Metabolic mapping reveals sex-dependent involvement of default mode and salience network in alexithymia. Soc Cogn Affect Neurosci 2015; 11:289-98. [PMID: 26341904 DOI: 10.1093/scan/nsv110] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2015] [Accepted: 08/31/2015] [Indexed: 11/14/2022] Open
Abstract
Alexithymia, a personality construct marked by difficulties in processing one's emotions, has been linked to the altered activity in the anterior cingulate cortex (ACC). Although longitudinal studies reported sex differences in alexithymia, what mediates them is not known. To investigate sex-specific associations of alexithymia and neuronal markers, we mapped metabolites in four brain regions involved differentially in emotion processing using a point-resolved spectroscopy MRS sequence in 3 Tesla. Both sexes showed negative correlations between alexithymia and N-acetylaspartate (NAA) in pregenual ACC (pgACC). Women showed a robust negative correlation of the joint measure of glutamate and glutamine (Glx) to NAA in posterior cingulate cortex (PCC), whereas men showed a weak positive association of Glx to NAA in dorsal ACC (dACC). Our results suggest that lowered neuronal integrity in pgACC, a region of the default mode network (DMN), might primarily account for the general difficulties in emotional processing in alexithymia. Association of alexithymia in women extends to another region in the DMN-PCC, while in men a region in the salience network (SN) was involved. These observations could be representative of sex specific regulation strategies that include diminished internal evaluation of feelings in women and cognitive emotion suppression in men.
Collapse
Affiliation(s)
- L Colic
- Clinical Affective Neuroimaging Laboratory, Magdeburg, Germany Leibniz Institute for Neurobiology, Magdeburg, Germany
| | - L R Demenescu
- Clinical Affective Neuroimaging Laboratory, Magdeburg, Germany Department of Neurology, Otto von Guericke University of Magdeburg, Magdeburg, Germany
| | - M Li
- Clinical Affective Neuroimaging Laboratory, Magdeburg, Germany Department of Neurology, Otto von Guericke University of Magdeburg, Magdeburg, Germany
| | - J Kaufmann
- Department of Neurology, Otto von Guericke University of Magdeburg, Magdeburg, Germany
| | - A L Krause
- Clinical Affective Neuroimaging Laboratory, Magdeburg, Germany Department of Psychiatry and Psychotherapy, Otto von Guericke University of Magdeburg, Magdeburg, Germany
| | - C Metzger
- Leibniz Institute for Neurobiology, Magdeburg, Germany Department of Psychiatry and Psychotherapy, Otto von Guericke University of Magdeburg, Magdeburg, Germany Institute for Cognitive Neurology and Dementia Research (IKND), Magdeburg, Germany
| | - M Walter
- Clinical Affective Neuroimaging Laboratory, Magdeburg, Germany Leibniz Institute for Neurobiology, Magdeburg, Germany Department of Neurology, Otto von Guericke University of Magdeburg, Magdeburg, Germany Department of Psychiatry and Psychotherapy, Otto von Guericke University of Magdeburg, Magdeburg, Germany Center for Behavioral Brain Sciences, Magdeburg, Germany
| |
Collapse
|
107
|
Walter M, Bentz D, Schicktanz N, Milnik A, Aerni A, Gerhards C, Schwegler K, Vogel M, Blum J, Schmid O, Roozendaal B, Lang UE, Borgwardt S, de Quervain D. Effects of cortisol administration on craving in heroin addicts. Transl Psychiatry 2015; 5. [PMID: 26218852 PMCID: PMC5068724 DOI: 10.1038/tp.2015.101] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/21/2022] Open
Abstract
Heroin dependence is a severe and chronically relapsing substance use disorder with limited treatment options. Stress is known to increase craving and drug-taking behavior, but it is not known whether the stress hormone cortisol mediates these stress effects or whether cortisol may rather reduce craving, for example, by interfering with addiction memory. The aim of the present study was to determine the effects of cortisol administration on craving in heroin-dependent patients and to determine whether the effects depend on the daily dose of heroin consumption. We used a double-blind, placebo-controlled, cross-over study in 29 heroin-dependent patients in a stable heroin-assisted treatment setting. A single oral dose of 20 mg of cortisol or placebo was administered 105 min before the daily heroin administration. The primary outcome measure was cortisol-induced change in craving. Secondary measures included anxiety, anger and withdrawal symptoms. For the visual analog scale for craving, we found a significant interaction (P = 0.0027) between study medication and heroin-dose group (that is, daily low, medium or high dose of heroin). Cortisol administration reduced craving in patients receiving a low dose of heroin (before heroin administration: P = 0.0019; after heroin administration: P = 0.0074), but not in patients receiving a medium or high dose of heroin. In a picture-rating task with drug-related pictures, cortisol administration did not affect the ratings for the picture-characteristic craving in all the three heroin-dose groups. Cortisol also did not significantly affect secondary outcome measures. In conclusion, a single administration of cortisol leads to reduced craving in low-dose heroin addicts. The present findings might have important clinical implications with regard to understanding stress effects and regarding treatment of addiction.
Collapse
Affiliation(s)
- M Walter
- Psychiatric University Clinics Basel, University of Basel, Basel, Switzerland,Psychiatric University Clinics Basel, University of Basel, Wilhelm Klein-Strasse 27, CH-4012 Basel, Switzerland E-mail:
| | - D Bentz
- Psychiatric University Clinics Basel, University of Basel, Basel, Switzerland,Division of Cognitive Neuroscience, Department of Psychology, University of Basel, Basel, Switzerland
| | - N Schicktanz
- Division of Cognitive Neuroscience, Department of Psychology, University of Basel, Basel, Switzerland
| | - A Milnik
- Psychiatric University Clinics Basel, University of Basel, Basel, Switzerland,Division of Molecular Neuroscience, Department of Psychology, University of Basel, Basel, Switzerland
| | - A Aerni
- Division of Cognitive Neuroscience, Department of Psychology, University of Basel, Basel, Switzerland
| | - C Gerhards
- Division of Cognitive Neuroscience, Department of Psychology, University of Basel, Basel, Switzerland
| | - K Schwegler
- Psychiatric University Clinics Basel, University of Basel, Basel, Switzerland,Division of Cognitive Neuroscience, Department of Psychology, University of Basel, Basel, Switzerland
| | - M Vogel
- Psychiatric University Clinics Basel, University of Basel, Basel, Switzerland
| | - J Blum
- Psychiatric University Clinics Basel, University of Basel, Basel, Switzerland
| | - O Schmid
- Psychiatric University Clinics Basel, University of Basel, Basel, Switzerland
| | - B Roozendaal
- Department of Cognitive Neuroscience, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, Nijmegen, Netherlands
| | - U E Lang
- Psychiatric University Clinics Basel, University of Basel, Basel, Switzerland
| | - S Borgwardt
- Psychiatric University Clinics Basel, University of Basel, Basel, Switzerland
| | - D de Quervain
- Psychiatric University Clinics Basel, University of Basel, Basel, Switzerland,Division of Cognitive Neuroscience, Department of Psychology, University of Basel, Basel, Switzerland,Transfaculty Research Platform, University of Basel, Basel, Switzerland,Division of Cognitive Neuroscience, University of Basel, Birmannsgasse 8, 4055 Basel, Switzerland. E-mail:
| |
Collapse
|
108
|
Walter M, Dürsteler K, Petitjean S, Wiesbeck G, Euler S, Sollberger D, Lang U, Vogel M. Psychosoziale Behandlungen bei Suchterkrankungen – Suchtspezifische Psychotherapieformen und ihre Wirksamkeit. Fortschr Neurol Psychiatr 2015; 83:201-10. [DOI: 10.1055/s-0034-1399338] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
109
|
Li M, Demenescu R, Metzger C, Walter M. Temporal Dynamics of Antidepressant Ketamine Effects On Glutamine Cycling Follow Regional Fingerprints of Ampa and Nmda Receptor Densities. Eur Psychiatry 2015. [DOI: 10.1016/s0924-9338(15)30573-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
110
|
Fittschen M, Lastres-Becker I, Halbach MV, Damrath E, Gispert S, Azizov M, Walter M, Müller S, Auburger G. Genetic ablation of ataxin-2 increases several global translation factors in their transcript abundance but decreases translation rate. Neurogenetics 2015; 16:181-92. [PMID: 25721894 PMCID: PMC4475250 DOI: 10.1007/s10048-015-0441-5] [Citation(s) in RCA: 42] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2015] [Accepted: 02/10/2015] [Indexed: 12/12/2022]
Abstract
Spinocerebellar ataxia type 2 (SCA2) and amyotrophic lateral sclerosis (ALS) are neurodegenerative disorders, caused or modified by an unstable CAG-repeat expansion in the SCA2 gene, which encodes a polyglutamine (polyQ) domain expansion in ataxin-2 (ATXN2). ATXN2 is an RNA-binding protein and interacts with the poly(A)-binding protein PABPC1, localizing to ribosomes at the rough endoplasmic reticulum. Under cell stress, ATXN2, PABPC1 and small ribosomal subunits are relocated to stress granules, where mRNAs are protected from translation and from degradation. It is unknown whether ATXN2 associates preferentially with specific mRNAs or how it modulates RNA processing. Here, we investigated the RNA profile of the liver and cerebellum from Atxn2 knockout (Atxn2 (-/-)) mice at two adult ages, employing oligonucleotide microarrays. Prominent increases were observed for Lsm12/Paip1 (>2-fold), translation modulators known as protein interactor/competitor of ATXN2 and for Plin3/Mttp (>1.3-fold), known as apolipoprotein modulators in agreement with the hepatosteatosis phenotype of the Atxn2 (-/-) mice. Consistent modest upregulations were also observed for many factors in the ribosome and the translation/secretion apparatus. Quantitative reverse transcriptase PCR in liver tissue validated >1.2-fold upregulations for the ribosomal biogenesis modulator Nop10, the ribosomal components Rps10, Rps18, Rpl14, Rpl18, Gnb2l1, the translation initiation factors Eif2s2, Eif3s6, Eif4b, Pabpc1 and the rER translocase factors Srp14, Ssr1, Sec61b. Quantitative immunoblots substantiated the increased abundance of NOP10, RPS3, RPS6, RPS10, RPS18, GNB2L1 in SDS protein fractions, and of PABPC1. In mouse embryonal fibroblasts, ATXN2 absence also enhanced phosphorylation of the ribosomal protein S6 during growth stimulation, while impairing the rate of overall protein synthesis rates, suggesting a block between the enhanced translation drive and the impaired execution. Thus, the physiological role of ATXN2 subtly modifies the abundance of cellular translation factors as well as global translation.
Collapse
Affiliation(s)
- M Fittschen
- Experimental Neurology, Goethe University Medical School, Theodor Stern Kai 7, 60590, Frankfurt am Main, Germany
| | | | | | | | | | | | | | | | | |
Collapse
|
111
|
Braune S, Groß M, Walter M, Zhou S, Dietze S, Rutschow S, Lendlein A, Tschöpe C, Jung F. Adhesion and activation of platelets from subjects with coronary artery disease and apparently healthy individuals on biomaterials. J Biomed Mater Res B Appl Biomater 2015; 104:210-7. [PMID: 25631281 DOI: 10.1002/jbm.b.33366] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2014] [Revised: 12/02/2014] [Accepted: 01/05/2015] [Indexed: 12/30/2022]
Abstract
On the basis of the clinical studies in patients with coronary artery disease (CAD) presenting an increased percentage of activated platelets, we hypothesized that hemocompatibility testing utilizing platelets from healthy individuals may result in an underestimation of the materials' thrombogenicity. Therefore, we investigated the interaction of polymer-based biomaterials with platelets from CAD patients in comparison to platelets from apparently healthy individuals. In vitro static thrombogenicity tests revealed that adherent platelet densities and total platelet covered areas were significantly increased for the low (polydimethylsiloxane, PDMS) and medium (Collagen) thrombogenic surfaces in the CAD group compared to the healthy subjects group. The area per single platelet-indicating the spreading and activation of the platelets-was markedly increased on PDMS treated with PRP from CAD subjects. This could not be observed for collagen or polytetrafluoroethylene (PTFE). For the latter material, platelet adhesion and surface coverage did not differ between the two groups. Irrespective of the substrate, the variability of these parameters was increased for CAD patients compared to healthy subjects. This indicates a higher reactivity of platelets from CAD patients compared to the healthy individuals. Our results revealed, for the first time, that utilizing platelets from apparently healthy donors bears the risk of underestimating the thrombogenicity of polymer-based biomaterials.
Collapse
Affiliation(s)
- S Braune
- Institute of Biomaterial Science, Helmholtz-Zentrum Geesthacht, Teltow, Germany
- Berlin-Brandenburg Center for Regenerative Therapies, Teltow and Berlin, Germany
- Institute of Chemistry, University of Potsdam, Potsdam, Germany
| | - M Groß
- Department of Cardiology and Pneumology, Charitè-Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany
| | - M Walter
- Institute of Biomaterial Science, Helmholtz-Zentrum Geesthacht, Teltow, Germany
- Berlin-Brandenburg Center for Regenerative Therapies, Teltow and Berlin, Germany
- Institute of Chemistry, University of Potsdam, Potsdam, Germany
| | - S Zhou
- Institute of Biomaterial Science, Helmholtz-Zentrum Geesthacht, Teltow, Germany
- Berlin-Brandenburg Center for Regenerative Therapies, Teltow and Berlin, Germany
- Institute of Chemistry, University of Potsdam, Potsdam, Germany
| | - S Dietze
- Institute of Biomaterial Science, Helmholtz-Zentrum Geesthacht, Teltow, Germany
- Berlin-Brandenburg Center for Regenerative Therapies, Teltow and Berlin, Germany
- Institute of Chemistry, University of Potsdam, Potsdam, Germany
| | - S Rutschow
- Department of Cardiology and Pneumology, Charitè-Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany
| | - A Lendlein
- Institute of Biomaterial Science, Helmholtz-Zentrum Geesthacht, Teltow, Germany
- Berlin-Brandenburg Center for Regenerative Therapies, Teltow and Berlin, Germany
- Institute of Chemistry, University of Potsdam, Potsdam, Germany
| | - C Tschöpe
- Berlin-Brandenburg Center for Regenerative Therapies, Teltow and Berlin, Germany
- Department of Cardiology, Charitè-Universitätsmedizin Berlin, Campus Virchow, Berlin, Germany
| | - F Jung
- Institute of Biomaterial Science, Helmholtz-Zentrum Geesthacht, Teltow, Germany
- Berlin-Brandenburg Center for Regenerative Therapies, Teltow and Berlin, Germany
| |
Collapse
|
112
|
Walter M, Lang U. “When I’m rushing on my run” – novel psychoactive substances. Swiss Med Wkly 2015; 145:w14091. [DOI: 10.4414/smw.2015.14091] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
|
113
|
Walter M, Stevenson O, Amponsah N, Scheper R, Rainham D, Hornblow C, Kerer U, Dryden G, Latter I, Butler R. Control of Neonectria ditissima with copper based products in New Zealand. ACTA ACUST UNITED AC 2015. [DOI: 10.30843/nzpp.2015.68.5798] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
New Zealand pipfruit crops require postharvest fungicides for control of European canker caused by Neonectria ditissima Fungicide efficacy trials to protect leaf scars from N ditissima infections were conducted during autumn 2013 and 2014 Disease control of artificially inoculated leaf scars was achieved by single applications of copper oxychloride and copper oxide but not copper hydroxide applied at 43 11 and 06 kg elemental copper/ ha respectively Control of leaf scar infections by copper oxide (065 and 095 kg elemental copper/ha) was similar to control by captan Leaf scars (010 days old) remained susceptible to infections up to 10 days after leaf fall; disease control was achieved by redistribution of copper and captan fungicides onto new leaf scars Disease control using copper oxide was consistent and similar to control using captan The copper product and concentration of elemental copper are important for successful control of leaf scar infections by N ditissima
Collapse
|
114
|
Carraro G, Maccato C, Gasparotto A, Barreca D, Walter M, Mayrhofer L, Moseler M, Venzo A, Seraglia R, Marega C. An old workhorse for new applications: Fe(dpm)3 as a precursor for low-temperature PECVD of iron(iii) oxide. Phys Chem Chem Phys 2015; 17:11174-81. [DOI: 10.1039/c5cp00435g] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
A combined theoretical–experimental investigation on Fe(dpm)3 as a precursor for PECVD of iron(iii) oxide is presented. Pure Fe2O3 nanomaterials have been obtained at temperatures as low as 100 °C, even on flexible plastic substrates.
Collapse
|
115
|
Lebl K, Zittra C, Silbermayr K, Obwaller A, Berer D, Brugger K, Walter M, Pinior B, Fuehrer HP, Rubel F. Mosquitoes (Diptera: Culicidae) and their relevance as disease vectors in the city of Vienna, Austria. Parasitol Res 2014; 114:707-13. [PMID: 25468380 PMCID: PMC4303709 DOI: 10.1007/s00436-014-4237-6] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2014] [Accepted: 11/14/2014] [Indexed: 11/16/2022]
Abstract
Mosquitoes (Diptera: Culicidae) are important vectors for a wide range of pathogenic organisms. As large parts of the human population in developed countries live in cities, the occurrence of vector-borne diseases in urban areas is of particular interest for epidemiologists and public health authorities. In this study, we investigated the mosquito occurrence in the city of Vienna, Austria, in order to estimate the risk of transmission of mosquito-borne diseases. Mosquitoes were captured using different sampling techniques at 17 sites in the city of Vienna. Species belonging to the Culex pipiens complex (78.8 %) were most abundant, followed by Coquillettidia richiardii (10.2 %), Anopheles plumbeus (5.4 %), Aedes vexans (3.8 %), and Ochlerotatus sticticus (0.7 %). Individuals of the Cx. pipiens complex were found at 80.2 % of the trap sites, while 58.8 % of the trap sites were positive for Cq. richiardii and Ae. vexans. Oc. sticticus was captured at 35.3 % of the sites, and An. plumbeus only at 23.5 % of the trap sites. Cx. pipiens complex is known to be a potent vector and pathogens like West Nile virus (WNV), Usutu virus (USUV), Tahyna virus (TAHV), Sindbis virus (SINV), Plasmodium sp., and Dirofilaria repens can be transmitted by this species. Cq. richiardii is a known vector species for Batai virus (BATV), SINV, TAHV, and WNV, while Ae. vexans can transmit TAHV, USUV, WNV, and Dirofilaria repens. An. plumbeus and Oc. sticticus seem to play only a minor role in the transmission of vector-borne diseases in Vienna. WNV, which is already wide-spread in Europe, is likely to be the highest threat in Vienna as it can be transmitted by several of the most common species, has already been shown to pose a higher risk in cities, and has the possibility to cause severe illness.
Collapse
Affiliation(s)
- Karin Lebl
- Institute for Veterinary Public Health, Department for Farm Animals and Veterinary Public Health, University of Veterinary Medicine Vienna, Veterinärplatz 1, 1210, Vienna, Austria,
| | | | | | | | | | | | | | | | | | | |
Collapse
|
116
|
Abstract
BACKGROUND Negative hallucinations are characterized by a defect in perception of an object or a person, or a denial of the existence of their perception. Negative hallucinations create blank spaces, due to both an impossible representation and an incapability of investment in reality. They have a close relationship with Cotard's syndrome, delusional theme of organ denial observed in melancholic syndromes in the elderly. METHODS Phenomenological approach. The phenomenology of negative hallucinations provides quite an amount of information on the origin of the psychotic symptoms when one is rather old. RESULTS The connections between hallucinations, mood disorders and negative symptoms are often difficult to live with for the nearest and dearest. Negative hallucinations require a strict approach to identify their expression that is crucial because a wide heterogeneity exists within the pathological pictures, as in Cotard's syndrome. Although the negative hallucination has an anti traumatic function in elderly people fighting against mental pain, it still represents a deficiency in symbolization. The prevalence of this symptom is without doubt underestimated, although its presence often underlines thymic suffering that is more striking. These hallucinatory symptoms have an important impact on the patients' daily life, and they appear to be prisoners of a suffering, which cannot be revealed. CONCLUSIONS We propose in this article to review the clinical symptoms of negative hallucinations in the elderly and the way to manage them. The medicinal approaches are not always effective. A greater place must be given to what is in connection with the body, aiming at a strong impact and thus to offer non-pharmacological approaches, such as somatic ones, which can be either invasive (electroconvulsive therapy) or not (transcranial magnetic stimulation).
Collapse
Affiliation(s)
- C Hazif-Thomas
- Service de l'intersecteur de psychiatrie du sujet âgé, hôpital de Bohars, CHU de Brest, route de Ploudalmézeau, 29820 Bohars, France; EA éthique professionnalisme et santé, EA 4486, université UBO, 29820 Bohars, France.
| | - F Stephan
- Service hospitalo-universitaire de psychiatrie adulte, hôpital de Bohars, CHRU de Brest, 29820 Bohars, France; EA laboratoire de neurosciences de Brest (EA 4685), UFR de médecine, université de Bretagne Occidentale, 22, avenue Camille-Desmoulins, CS 93837, 29230 Brest cedex 3, France
| | - M Walter
- EA éthique professionnalisme et santé, EA 4486, université UBO, 29820 Bohars, France; Service hospitalo-universitaire de psychiatrie adulte, hôpital de Bohars, CHRU de Brest, 29820 Bohars, France; EA laboratoire de neurosciences de Brest (EA 4685), UFR de médecine, université de Bretagne Occidentale, 22, avenue Camille-Desmoulins, CS 93837, 29230 Brest cedex 3, France
| | - P Thomas
- Centre Jean-Marie-Léger, CHU de Limoges, 87025 Limoges, France
| |
Collapse
|
117
|
Ruof J, Staab TR, Walter M. Dilemma of Cross-Over Trials and Their Impact on Benefit Assessment In Oncology. Value Health 2014; 17:A658. [PMID: 27202389 DOI: 10.1016/j.jval.2014.08.2407] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
- J Ruof
- Roche Pharma, Grenzach-Wyhlen, Germany
| | - T R Staab
- Roche Pharma, Grenzach-Wyhlen, Germany
| | | |
Collapse
|
118
|
Salaün A, Le Galudec M, Saliou P, Walter M. Le syndrome métabolique : prévalence et analyse des pratiques, résultats d’une expérience menée au CHRU de Brest. Eur Psychiatry 2014. [DOI: 10.1016/j.eurpsy.2014.09.250] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
Abstract
ContexteLa prévalence du syndrome métabolique est nettement plus élevée chez les patients schizophrènes que dans la population générale, pouvant atteindre 41 % [1]. Par ailleurs, il est responsable d’un risque cardiovasculaire accru [2] ainsi que d’une augmentation du risque de diabète de type 2. Ainsi, la mortalité totale est deux à trois fois plus élevée chez les personnes souffrant de schizophrénie [3].ObjectifObtenir une prévalence du syndrome métabolique dans une population de schizophrènes suivis en ambulatoires et évaluer la qualité de l’identification de ce syndrome ainsi que de sa prise en charge.MéthodeDes patients schizophrènes, sous antipsychotiques depuis au moins 3 mois, ont été inclus lors d’une première consultation par leur psychiatre traitant dans le cadre de leur suivi habituel. Des mesures comprenant un bilan biologique (HDLc, glycémie, triglycérides…), la passation d’un entretien diagnostique structuré (le MINI), des mesures cliniques (tension artérielle, tour de taille, etc) ont été réalisées. Les patients ont été revus lors d’une seconde consultation par leur psychiatre traitant avec les résultats du bilan biologique. Enfin, nous avons effectué une hétéro-évaluation des pratiques professionnelles.RésultatsVingt et un patients ont été inclus dans l’étude, 3 ont été perdus de vue. La prévalence du syndrome métabolique s’élève à 38,9 %. Par ailleurs, 22,2 % des sujets répondent à 2 critères de la définition du syndrome métabolique. Seulement 42,9 % des syndromes métaboliques étaient bien identifiés par les psychiatres. L’action la plus fréquemment mise en place était les règles hygiéno-diététiques (71,4 % chez les patients avec syndrome métabolique). Enfin, aucun patient ne bénéficiait d’un suivi tensionnel et très peu d’un suivi du bilan biologique (28,6 % chez les sujets avec syndrome métabolique et 54,5 % chez les sujets sans syndrome métabolique).
Collapse
|
119
|
Rall K, Eisenbeis S, Barresi G, Walter M, Poths S, Wallwiener D, Riess O, Brucker S, Bonin M. Mayer-Rokitansky-Küster-Hauser-Syndrom in 5 diskordanten monozygoten Zwillingen: MMP14, LRP10, und Extrazellulärmatrix- sowie Neoangiogenese-Gene als potentielle Kandidaten innerhalb eines gewebsspezifischen Mosaiks. Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1388591] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
120
|
Abstract
Non-invasive estimation of bladder volume is required to progress from scheduled voiding to a demand-driven emptying scheme for patients with impaired bladder volume sensation. Electrical impedance tomography (EIT) is a promising candidate for the non-invasive monitoring of bladder volume. This article focuses on four estimation algorithms used to map recorded EIT data to a volume estimate. Two different approaches are presented: the tomographic algorithms (one based on global impedance, the other on equivalent circular diameter) rely on the reconstruction of a tomographic image and then extract a volume estimate, whereas the parametric algorithms (one based on neural networks, the other on the singular value difference method) directly map the raw data to a volume estimate. The four algorithms presented here are evaluated for volume estimation error, noise tolerance and suppression of varying urine conductivity based on finite element simulation data.
Collapse
Affiliation(s)
- T Schlebusch
- Chair for Medical Information Technology, Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstr. 20, 52074 Aachen, Germany
| | | | | | | |
Collapse
|
121
|
van Tol MJ, Li M, Metzger CD, Hailla N, Horn DI, Li W, Heinze HJ, Bogerts B, Steiner J, He H, Walter M. Local cortical thinning links to resting-state disconnectivity in major depressive disorder. Psychol Med 2014; 44:2053-2065. [PMID: 24176247 DOI: 10.1017/s0033291713002742] [Citation(s) in RCA: 88] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
BACKGROUND Local structural and metabolic as well as inter-regional connectivity abnormalities have been implicated in the neuropathology of major depressive disorder (MDD). How local tissue properties affect intrinsic functional connectivity is, however, unclear. Using a cross-sectional, multi-modal imaging approach, we investigated the relationship between local cortical tissue abnormalities and intrinsic resting-state functional connectivity (RSFC) in MDD. METHOD A total of 20 MDD in-patients and 20 healthy controls underwent magnetic resonance imaging at 3 T for structural and functional imaging. Whole-brain cortical thickness was calculated and compared between groups. Regions with reduced cortical thickness defined seeds for subsequent whole-brain RSFC analyses. Contributions of structural tissue abnormalities on inter-regional RSFC were explicitly investigated. RESULTS Lower cortical thickness was observed in MDD in the right dorsomedial prefrontal cortex (PFC), superior temporal gyrus/temporal pole, middle-posterior cingulate cortex, and dorsolateral PFC. No differences in local fractional amplitude of low-frequency fluctuations were observed. Lower thickness in patients' dorsomedial PFC further directly and selectively affected its RSFC with the precuneus, which was unaffected by symptom severity. No effects of cortical thickness in other regions showing abnormal thickness were observed to influence functional connectivity. CONCLUSIONS Abnormal cortical thickness in the dorsomedial PFC in MDD patients was observed to selectively and directly affect its intrinsic connectivity with the precuneus in MDD patients independent of depression severity, thereby marking a potential vulnerability for maladaptive mood regulation. Future studies should include an unmedicated sample and replicate findings using independent component analysis to test for morphometric effects on network integrity.
Collapse
Affiliation(s)
- M-J van Tol
- NeuroImaging Center,University Medical Center Groningen, University of Groningen,Groningen,The Netherlands
| | - M Li
- Leibniz Institute for Neurobiology, Magdeburg,Germany
| | - C D Metzger
- Leibniz Institute for Neurobiology, Magdeburg,Germany
| | - N Hailla
- Clinical Affective Neuroimaging Laboratory,Center for Behavioral Brain Sciences,Magdeburg,Germany
| | - D I Horn
- Clinical Affective Neuroimaging Laboratory,Center for Behavioral Brain Sciences,Magdeburg,Germany
| | - W Li
- Leibniz Institute for Neurobiology, Magdeburg,Germany
| | - H J Heinze
- Leibniz Institute for Neurobiology, Magdeburg,Germany
| | - B Bogerts
- Department of Psychiatry and Psychotherapy,Otto von Guericke University,Magdeburg,Germany
| | - J Steiner
- Department of Psychiatry and Psychotherapy,Otto von Guericke University,Magdeburg,Germany
| | - H He
- State Key Laboratory of Management and Control for Complex Systems, Institute of Automation,Chinese Academy of Sciences,Beijing,People's Republic of China
| | - M Walter
- Leibniz Institute for Neurobiology, Magdeburg,Germany
| |
Collapse
|
122
|
Deutschenbaur L, Lambert M, Walter M, Naber D, Huber CG. [Long-term treatment of schizophrenia spectrum disorders: focus on pharmacotherapy]. Nervenarzt 2014; 85:363-75; quiz 376-7. [PMID: 24603949 DOI: 10.1007/s00115-013-3807-7] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
Schizophrenia spectrum disorders (SSD) constitute a group of psychiatric illnesses which frequently lead to persisting mental impairment. Although some patients show a clinical course with few episodes and good long-term outcome, the course of the disease is often chronic and unfavorable. Long-term treatment (LTT) of SSD pertains to the postacute stabilization period and the remission period following pharmacological and psychosocial therapy of an acute illness episode. This article provides an overview of treatment recommendations concerning long-term pharmacotherapy, dealing with side effects, treatment of non-response and therapy resistance and the treatment of psychiatric comorbidities. Furthermore, an overview of non-pharmacological treatment options is presented. An integrated therapeutic setting combining evidence-based pharmacotherapy, psychosocial interventions, and supportive therapies is recommended for optimal LTT of SSD. Considering the limited financial resources available in the healthcare system, one of the major challenges is to provide patients with access to the evidence-based treatment options available.
Collapse
Affiliation(s)
- L Deutschenbaur
- Universitäre Psychiatrische Kliniken Basel, Wilhelm Klein-Str. 27, 4012, Basel, Schweiz
| | | | | | | | | |
Collapse
|
123
|
Niederlaender J, Walter M, Krajewski S, Schweizer E, Post M, Schille C, Geis-Gerstorfer J, Wendel HP. Cytocompatibility evaluation of different biodegradable magnesium alloys with human mesenchymal stem cells. J Mater Sci Mater Med 2014; 25:835-843. [PMID: 24327112 DOI: 10.1007/s10856-013-5119-7] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/05/2013] [Accepted: 11/29/2013] [Indexed: 06/03/2023]
Abstract
In the last few years, the use of biodegradable magnesium (Mg) alloys has evoked great interest in the orthopedic field due to great advantages over long-term implant materials associated with various side effects like allergy and sensitization and consequent implant removal surgeries. However, degradation of these Mg alloys results in ion release, which may cause severe cytotoxicity and undesirable complications after implantation. In this study, we investigated the cytological effects of various Mg alloys on cells that play an important role in bone repair. Eight different magnesium alloys containing varying amounts of Al, Zn, Nd and Y were either incubated directly or indirectly with the osteosarcoma cell line Saos-2 or with uninduced and osteogenically-induced human mesenchymal stem cells (MSCs) isolated from bone marrow specimens obtained from the femoral shaft of patients undergoing total hip replacement. Cell viability, cell attachment and the release of ions were investigated at different time points in vitro. During direct or indirect incubation different cytotoxic effects of the Mg alloys on Saos-2 cells and osteogenically-induced or uninduced MSCs were observed. Furthermore, the concentration of degradation products released from the Mg alloys differed. Overall, Mg alloys MgNd2, MgY4, MgAl9Zn1 and MgY4Nd2 exhibit good cytocompatibility. In conclusion, this study reveals the necessity of cytocompatibility evaluation of new biodegradable magnesium alloys with cells that will get in direct contact to the implant material. Furthermore, the use of standardized experimental in vitro assays is necessary in order to reliably and effectively characterize new Mg alloys before performing in vivo experiments.
Collapse
Affiliation(s)
- J Niederlaender
- Clinical Research Laboratory, Department of Thoracic, Cardiac and Vascular Surgery, University Hospital Tuebingen, Tuebingen University, Calwerstr. 7/1, 72076, Tuebingen, Germany
| | | | | | | | | | | | | | | |
Collapse
|
124
|
Smieskova R, Marmy J, Schmidt A, Bendfeldt K, Riecher-Rӧssler A, Walter M, Lang UE, Borgwardt S. Do subjects at clinical high risk for psychosis differ from those with a genetic high risk?--A systematic review of structural and functional brain abnormalities. Curr Med Chem 2014; 20:467-81. [PMID: 23157639 PMCID: PMC3580804 DOI: 10.2174/0929867311320030018] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2012] [Revised: 10/25/2012] [Accepted: 10/30/2012] [Indexed: 11/22/2022]
Abstract
Introduction: Pre-psychotic and early psychotic characteristics are investigated in the high-risk (HR) populations for psychosis. There are two different approaches based either on hereditary factors (genetic high risk, G-HR) or on the clinically manifested symptoms (clinical high risk, C-HR). Common features are an increased risk for development of psychosis and similar cognitive as well as structural and functional brain abnormalities. Methods: We reviewed the existing literature on longitudinal structural, and on functional imaging studies, which included G-HR and/or C-HR individuals for psychosis, healthy controls (HC) and/or first episode of psychosis (FEP) or schizophrenia patients (SCZ). Results: With respect to structural brain abnormalities, vulnerability to psychosis was associated with deficits in frontal, temporal, and cingulate regions in HR, with additional insular and caudate deficits in C-HR population. Furthermore, C-HR had progressive prefrontal deficits related to the transition to psychosis. With respect to functional brain abnormalities, vulnerability to psychosis was associated with prefrontal, cingulate and middle temporal abnormalities in HR, with additional parietal, superior temporal, and insular abnormalities in C-HR population. Transition-to-psychosis related differences emphasized prefrontal, hippocampal and striatal components, more often detectable in C-HR population. Multimodal studies directly associated psychotic symptoms displayed in altered prefrontal and hippocampal activations with striatal dopamine and thalamic glutamate functions. Conclusion: There is an evidence for similar structural and functional brain abnormalities within the whole HR population, with more pronounced deficits in the C-HR population. The most consistent evidence for abnormality in the prefrontal cortex reported in structural, functional and multimodal studies of HR population may underlie the complexity of higher cognitive functions that are impaired during HR mental state for psychosis.
Collapse
Affiliation(s)
- R Smieskova
- Department of Psychiatry, University of Basel, c/o University Hospital Basel, Petersgraben 4, Basel 4031, Switzerland.
| | | | | | | | | | | | | | | |
Collapse
|
125
|
Braune S, Walter M, Schulze F, Lendlein A, Jung F. Changes in platelet morphology and function during 24 hours of storage. Clin Hemorheol Microcirc 2014; 58:159-70. [DOI: 10.3233/ch-141876] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Affiliation(s)
- S. Braune
- Institute of Biomaterial Science and Berlin-Brandenburg Center for Regenerative Therapies, Helmholtz-Zentrum Geesthacht, Teltow, Germany
- Institute of Chemistry, University of Potsdam, Potsdam, Germany
| | - M. Walter
- Institute of Biomaterial Science and Berlin-Brandenburg Center for Regenerative Therapies, Helmholtz-Zentrum Geesthacht, Teltow, Germany
- Institute of Chemistry, University of Potsdam, Potsdam, Germany
| | - F. Schulze
- Institute of Biomaterial Science and Berlin-Brandenburg Center for Regenerative Therapies, Helmholtz-Zentrum Geesthacht, Teltow, Germany
| | - A. Lendlein
- Institute of Biomaterial Science and Berlin-Brandenburg Center for Regenerative Therapies, Helmholtz-Zentrum Geesthacht, Teltow, Germany
- Institute of Chemistry, University of Potsdam, Potsdam, Germany
| | - F. Jung
- Institute of Biomaterial Science and Berlin-Brandenburg Center for Regenerative Therapies, Helmholtz-Zentrum Geesthacht, Teltow, Germany
| |
Collapse
|
126
|
Agostini M, Allardt M, Andreotti E, Bakalyarov AM, Balata M, Barabanov I, Barnabé Heider M, Barros N, Baudis L, Bauer C, Becerici-Schmidt N, Bellotti E, Belogurov S, Belyaev ST, Benato G, Bettini A, Bezrukov L, Bode T, Brudanin V, Brugnera R, Budjáš D, Caldwell A, Cattadori C, Chernogorov A, Cossavella F, Demidova EV, Domula A, Egorov V, Falkenstein R, Ferella A, Freund K, Frodyma N, Gangapshev A, Garfagnini A, Gotti C, Grabmayr P, Gurentsov V, Gusev K, Guthikonda KK, Hampel W, Hegai A, Heisel M, Hemmer S, Heusser G, Hofmann W, Hult M, Inzhechik LV, Ioannucci L, Janicskó Csáthy J, Jochum J, Junker M, Kihm T, Kirpichnikov IV, Kirsch A, Klimenko A, Knöpfle KT, Kochetov O, Kornoukhov VN, Kuzminov VV, Laubenstein M, Lazzaro A, Lebedev VI, Lehnert B, Liao HY, Lindner M, Lippi I, Liu X, Lubashevskiy A, Lubsandorzhiev B, Lutter G, Macolino C, Machado AA, Majorovits B, Maneschg W, Misiaszek M, Nemchenok I, Nisi S, O'Shaughnessy C, Pandola L, Pelczar K, Pessina G, Pullia A, Riboldi S, Rumyantseva N, Sada C, Salathe M, Schmitt C, Schreiner J, Schulz O, Schwingenheuer B, Schönert S, Shevchik E, Shirchenko M, Simgen H, Smolnikov A, Stanco L, Strecker H, Tarka M, Ur CA, Vasenko AA, Volynets O, von Sturm K, Wagner V, Walter M, Wegmann A, Wester T, Wojcik M, Yanovich E, Zavarise P, Zhitnikov I, Zhukov SV, Zinatulina D, Zuber K, Zuzel G. Results on neutrinoless double-β decay of 76Ge from phase I of the GERDA experiment. Phys Rev Lett 2013; 111:122503. [PMID: 24093254 DOI: 10.1103/physrevlett.111.122503] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/17/2013] [Indexed: 06/02/2023]
Abstract
Neutrinoless double beta decay is a process that violates lepton number conservation. It is predicted to occur in extensions of the standard model of particle physics. This Letter reports the results from phase I of the Germanium Detector Array (GERDA) experiment at the Gran Sasso Laboratory (Italy) searching for neutrinoless double beta decay of the isotope (76)Ge. Data considered in the present analysis have been collected between November 2011 and May 2013 with a total exposure of 21.6 kg yr. A blind analysis is performed. The background index is about 1 × 10(-2) counts/(keV kg yr) after pulse shape discrimination. No signal is observed and a lower limit is derived for the half-life of neutrinoless double beta decay of (76)Ge, T(1/2)(0ν) >2.1 × 10(25) yr (90% C.L.). The combination with the results from the previous experiments with (76)Ge yields T(1/2)(0ν)>3.0 × 10(25) yr (90% C.L.).
Collapse
Affiliation(s)
- M Agostini
- Physik Department and Excellence Cluster Universe, Technische Universität München, Germany
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
127
|
Sämann PG, Elbau I, Spoormaker VI, Viviani R, Walter M, Czisch M. What is the metabolic cost of functional connectivity in the brain? A combined fMRI-BOLD-arterial spin labelling perfusion study. Pharmacopsychiatry 2013. [DOI: 10.1055/s-0033-1353316] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
128
|
Abstract
A system for classification of motion patterns is presented based on a non-contact magnetic induction monitoring device. This device is textile integrated, wearable, and able to measure pulse and respiratory activity. The proposed classifiers are a neural network, support vector machine, and a decision tree algorithm generated by bootstrap aggregating. Their performance is compared using a data set comprising five different types of motion patterns. In addition, the dependence of the misclassification error on the input sample length is investigated. The features used for classification were based on information derived by discrete wavelet transform and on lower and higher order statistical measures. With the presented magnetic induction device, all tested classifiers were able to classify the defined motion pattern with an accuracy of over 93%. The proposed bootstrap aggregating decision tree algorithm produces the best classification performance (accuracy of 96%). The support vector machine classifier shows the least dependence on the sample length.
Collapse
Affiliation(s)
- D Teichmann
- Philips Chair for Medical Information Technology, RWTH Aachen University, Pauwelsstr. 20, D-52074 Aachen, Germany.
| | | | | | | |
Collapse
|
129
|
Rabbitt L, McDonald C, Savage S, Walter M, Rubis C, Schwartz N. High-performing face recognizers use eye-eye distance and eye-nose distance more than low-performing face recognizers. J Vis 2013. [DOI: 10.1167/13.9.978] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
130
|
Schreeb A, Walter M, Odadzic D, Schwed JS, Weizel L, Stark H. Piperazine modification in 2,4,6-triaminopyrimidine derivatives as histamine H4 receptor ligands. Pharmazie 2013; 68:521-525. [PMID: 23923631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
The human histamine H4 receptor (hH4R) is a promising new target in the therapy of inflammatory and immunomodulatory diseases. The 2,4,6-triaminopyrimidine structure has been established as a potent hH4R affinity scaffold. By using the inverse agonist ST-1012 as reference ligand, piperazine modifications were performed to get larger structural variations. Therefore, different spacers were introduced into the lead structure and the influence on affinity of this basic element was evaluated. While a short distance between aminopyrimidine and basic moiety is beneficial, a lipophilic group in the eastern part is necessary to maintain hH4R affinity.
Collapse
Affiliation(s)
- A Schreeb
- Institute of Pharmaceutical and Medicinal Chemistry, Biozentrum, Goethe University, ZAFES/CMP/IZNF, Frankfurt, Germany
| | | | | | | | | | | |
Collapse
|
131
|
Walter M, van ’t Spijker A, Pasma A, Hazes J, Luime J. AB1422-HPR Discrepancies between disease activity and disease burden. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.1414] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
132
|
Maître E, Debien C, Nicaise P, Wyngaerden F, Le Galudec M, Genest P, Ducrocq F, Delamillieure P, Lavoisy B, Walter M, Dubois V, Vaiva G. [Advanced directives in psychiatry: A review of the qualitative literature, a state-of-the-art and viewpoints]. Encephale 2013; 39:244-51. [PMID: 23537636 DOI: 10.1016/j.encep.2012.10.012] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2012] [Accepted: 10/22/2012] [Indexed: 11/19/2022]
Abstract
BACKGROUND Advance Directives are written documents, which are used for people to notify their preference for a future situation when they are unable to give their consent. In psychiatry, psychiatric advance directives (PADs) can be used for patients with chronic psychotic disorders such as schizophrenia, or a bipolar disorder. PADs give the patient an opportunity to state wishes in advance about his/her treatment when he/she is in an acute state of illness. PADs were initially developed as a way for patients to defend themselves against the power of the psychiatrists, but are likely to become a useful tool in psychiatric care. PADs may contain information about medication, non pharmaceutical devices, and the name of a proxy decision maker. The main objective is to reduce the number of compulsory hospitalisations. OBJECTIVE This article is a qualitative review which carries out a state-of-the-art on the use of PADs for people with chronic psychotic disorders and defines suggestions to include this intervention in the French psychiatric context. METHOD We used the keywords psychiatric advance directives, crisis card, Ulysse directives, joint crisis plan (JCP) in the MEDLINE database to propose a qualitative review. We selected original clinical studies about the use of PADs for people with psychotic disorders. RESULTS We included 36 articles. The qualitative analysis identified seven main themes: different types of PADs, effectiveness of PADs, practical use of PADs, patient's views, clinician's views, economical aspects, and legal aspects. The content of the PADs is consistent with psychiatric standard care in nearly all cases, regarding medical instructions, pre-emergency interventions, non-hospital alternatives and non-medical personal care. Patients use their PADs to describe prodromal symptoms of relapse and to suggest a treatment and a hospitalisation in advance. PADs are not used to refuse all treatments. Patients show a strong interest in creating a directive and a high level of satisfaction when using it. They feel they have more control over their mental health problem and are more respected and valued as a person. Thirty-six to fifty-three percent of clinicians had positive opinions regarding PADs. They valued the increase of the patient's autonomy and the prevention of relapse, but were concerned about difficulties for accessing the documents, and about the lack of training of the medical teams. Clinicians also feared the pressure of relatives or partners on treatment decisions. The qualitative analysis revealed the specific benefit of the JCP, a particular type of PADs negotiated with the medical team, on the reduction of the general number of admissions. We can identify practical problems such as the lack of accessibility to PADs in emergency situations, and the clinician's reluctance to use PADs. The only economical evaluation showed a non-significant decrease in total costs. DISCUSSION PADs are used in a few countries, although their benefits in terms of patient's perceptions and compulsory admissions are promising. The JCP proposes a specific clinical approach based on therapeutic alliance. Its creation also involves the clinician, family members and a neutral mediator in a negotiated process. The JCP is likely to be the most efficient PAD model in reducing compulsory admissions. The use of the JCP appears to be relevant in the context of the new French legislation, establishing outpatient commitment orders and could be an effective way to improve the relationships with patients.
Collapse
Affiliation(s)
- E Maître
- Pôle de psychiatrie, médecine légale et médecine en milieu pénitentiaire, service de psychiatrie adulte, université Lille Nord de France, hôpital Michel-Fontan, CHRU de Lille, rue André-Verhaeghe, 59037 Lille cedex, France
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
133
|
Lebl K, Nischler EM, Walter M, Brugger K, Rubel F. First record of the disease vector Anopheles hyrcanus in Austria. J Am Mosq Control Assoc 2013; 29:59-60. [PMID: 23687857 DOI: 10.2987/12-6282.1] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
Anopheles (Anopheles) hyrcanus was detected for the first time in Austria, in a floodplain forest in the city of Vienna. From May to September 2012, we found 135 females of this species within the scope of a mosquito monitoring program. Anopheles hyrcanus transmits Sindbis and Tahyna viruses and was reported to be a potential vector for human malaria and dirofilariasis. An updated distribution map depicts that An. hyrcanus has extended its range northwards across the European Alps.
Collapse
Affiliation(s)
- Karin Lebl
- University of Veterinary Medicine Vienna, Institute for Veterinary Public Health, Veterinärplatz 1, 1210 Vienna, Austria
| | | | | | | | | |
Collapse
|
134
|
Walter M, Denier N, Vogel M, Lang U. Effects of Psychoactive Substances in Schizophrenia – Findings of Structural and Functional Neuroimaging. Curr Top Med Chem 2013. [DOI: 10.2174/1568026611212210013] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
135
|
Grünert SC, Müllerleile S, De Silva L, Barth M, Walter M, Walter K, Meissner T, Lindner M, Ensenauer R, Santer R, Bodamer OA, Baumgartner MR, Brunner-Krainz M, Karall D, Haase C, Knerr I, Marquardt T, Hennermann JB, Steinfeld R, Beblo S, Koch HG, Konstantopoulou V, Scholl-Bürgi S, van Teeffelen-Heithoff A, Suormala T, Sperl W, Kraus JP, Superti-Furga A, Schwab KO, Sass JO. Propionic acidemia: clinical course and outcome in 55 pediatric and adolescent patients. Orphanet J Rare Dis 2013; 8:6. [PMID: 23305374 PMCID: PMC3568723 DOI: 10.1186/1750-1172-8-6] [Citation(s) in RCA: 112] [Impact Index Per Article: 10.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2012] [Accepted: 01/07/2013] [Indexed: 12/29/2022] Open
Abstract
Background Propionic acidemia is an inherited disorder caused by deficiency of propionyl-CoA carboxylase. Although it is one of the most frequent organic acidurias, information on the outcome of affected individuals is still limited. Study design/methods Clinical and outcome data of 55 patients with propionic acidemia from 16 European metabolic centers were evaluated retrospectively. 35 patients were diagnosed by selective metabolic screening while 20 patients were identified by newborn screening. Endocrine parameters and bone age were evaluated. In addition, IQ testing was performed and the patients’ and their families’ quality of life was assessed. Results The vast majority of patients (>85%) presented with metabolic decompensation in the neonatal period. Asymptomatic individuals were the exception. About three quarters of the study population was mentally retarded, median IQ was 55. Apart from neurologic symptoms, complications comprised hematologic abnormalities, cardiac diseases, feeding problems and impaired growth. Most patients considered their quality of life high. However, according to the parents’ point of view psychic problems were four times more common in propionic acidemia patients than in healthy controls. Conclusion Our data show that the outcome of propionic acidemia is still unfavourable, in spite of improved clinical management. Many patients develop long-term complications affecting different organ systems. Impairment of neurocognitive development is of special concern. Nevertheless, self-assessment of quality of life of the patients and their parents yielded rather positive results.
Collapse
Affiliation(s)
- Sarah C Grünert
- Labor für Klinische Biochemie und Stoffwechsel, Zentrum für Kinder- und Jugendmedizin, Universitätsklinikum Freiburg, Freiburg, Germany
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
136
|
Gensch U, Walter M. Preface. EPJ Web of Conferences 2013. [DOI: 10.1051/epjconf/20135200001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
137
|
Smieskova R, Marmy J, Schmidt A, Bendfeldt K, Riecher-Rossler A, Walter M, E. Lang U, Borgwardt S. Do Subjects at Clinical High Risk for Psychosis Differ from those with a Genetic High Risk? - A Systematic Review of Structural and Functional Brain Abnormalities. Curr Med Chem 2013. [DOI: 10.2174/092986713804870756] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
138
|
|
139
|
Walter M, Denier N, Vogel M, Lang U. Effects of Psychoactive Substances in Schizophrenia – Findings of Structural and Functional Neuroimaging. Curr Top Med Chem 2012; 12:2426-33. [PMID: 23279181 DOI: 10.2174/156802612805289971] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2012] [Revised: 08/31/2012] [Accepted: 09/21/2012] [Indexed: 11/22/2022]
|
140
|
Sass JO, Walter M, Shield JPH, Atherton AM, Garg U, Scott D, Woods CG, Smith LD. 3-Hydroxyisobutyrate aciduria and mutations in the ALDH6A1 gene coding for methylmalonate semialdehyde dehydrogenase. J Inherit Metab Dis 2012; 35:437-42. [PMID: 21863277 DOI: 10.1007/s10545-011-9381-x] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/07/2011] [Revised: 07/22/2011] [Accepted: 07/27/2011] [Indexed: 01/26/2023]
Abstract
3-hydroxyisobutyric aciduria is an organic aciduria with a poorly understood biochemical basis. It has previously been assumed that deficiency of 3-hydroxyisobutyrate dehydrogenase (HIBADH) in the valine catabolic pathway is the underlying enzyme defect, but more recent evidence makes it likely that individuals with 3-hydroxyisobutyryic aciduria represent a heterogeneous group with different underlying mechanisms, including respiratory chain defects or deficiency of methylmalonate semialdehyde dehydrogenase. However, to date methylmalonate semialdehyde dehydrogenase deficiency has only been demonstrated at the gene level for a single individual. We present two unrelated patients who presented with developmental delay and increased urinary concentrations of 3-hydroxyisobutyric acid. Both children were products of consanguineous unions and were of European or Pakistani descent. One patient developed a febrile illness and subsequently died from a hepatoencephalopathy at 2 years of age. Further studies were initiated and included tests of the HIBADH enzyme in fibroblast homogenates, which yielded normal activities. Sequencing of the ALDH6A1 gene (encoding methylmalonate semialdehyde dehydrogenase) suggested homozygosity for the missense mutation c.785 C > A (S262Y) in exon 7 which was not found in 210 control alleles. Mutation analysis of the ALDH6A1 gene of the second patient confirmed the presence of a different missense mutation, c.184 C > T (P62S), which was also identified in 1/530 control chromosomes. Both mutations affect highly evolutionarily conserved amino acids of the methylmalonate semialdehyde dehydrogenase protein. Mutation analysis in the ALDH6A1 gene can reveal a cause of 3-hydroxyisobutyric aciduria, which may present with only slightly increased urinary levels of 3-hydroxyisobutyric acid, if a patient is metabolically stable.
Collapse
Affiliation(s)
- Jörn Oliver Sass
- Labor für Klinische Biochemie und Stoffwechsel, Zentrum für Kinder- und Jugendmedizin, Universitätsklinikum Freiburg, Mathildenstr. 1, 79106 Freiburg, Germany.
| | | | | | | | | | | | | | | |
Collapse
|
141
|
|
142
|
Li M, He HG, Shi W, Li J, Lv B, Wang CH, Miao QW, Wang ZC, Wang NL, Walter M, Sabel BA. Quantification of the human lateral geniculate nucleus in vivo using MR imaging based on morphometry: volume loss with age. AJNR Am J Neuroradiol 2012; 33:915-21. [PMID: 22245591 DOI: 10.3174/ajnr.a2884] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
BACKGROUND AND PURPOSE Because it is a small subcortical structure, the precise measurement of the human LGN is still a technical challenge. In this article, we identify the LGN in vivo, measure its volume based on high-resolution MR imaging, and then relate its volume to subject age to evaluate the potential clinical application. MATERIALS AND METHODS A semiautomatic LGN isolation method was developed on scans obtained with 1.5T MR imaging, which involves highlighting the surrounding landmarks, obtaining candidate LGN voxels with a region-growing algorithm, and isolating the LGN from the ventral diencephalon. The method was accessed with a test-retest reliability on the results from 55 healthy subjects at different ages. RESULTS This method showed high test-retest within-subject reliability (ICC, 0.950 and 0.948 in left and right hemispheres, respectively) among 3 independent measurements in each subject. The unilateral volume was highly variable, ranging from 52 to 102 mm(3) in the left and 66 to 105 mm(3) in the right hemisphere, with significantly larger volumes on the right (86 mm(3)) than on the left (77 mm(3)). The combined bilateral volumes (controlled for ICV) significantly decreased in size with progressing age from 20 to 65 years (r = -0.512, P = .000). There was no sex difference in bilateral LGN volumes (male/female: 163.1 ± 18.2/162.2 ± 21.4 mm(3)). CONCLUSIONS Using our new technique, we were able to reliably determine the human LGN volume in vivo, which was found to decline with age. The volumes obtained by our method corresponded well with previously reported postmortem values, so our method may be considered to be superior for investigating the pathology of LGN.
Collapse
Affiliation(s)
- M Li
- State Key Laboratory of Management and Control for Complex Systems, Institute of Automation, Chinese Academy of Sciences, Beijing, China
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
143
|
Grünert SC, Müllerleile S, de Silva L, Barth M, Walter M, Walter K, Meissner T, Lindner M, Ensenauer R, Santer R, Bodamer OA, Baumgartner MR, Brunner-Krainz M, Karall D, Haase C, Knerr I, Marquardt T, Hennermann JB, Steinfeld R, Beblo S, Koch HG, Konstantopoulou V, Scholl-Bürgi S, van Teeffelen-Heithoff A, Suormala T, Sperl W, Kraus JP, Superti-Furga A, Schwab KO, Sass JO. Propionic acidemia: neonatal versus selective metabolic screening. J Inherit Metab Dis 2012; 35:41-9. [PMID: 22134541 DOI: 10.1007/s10545-011-9419-0] [Citation(s) in RCA: 56] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/23/2011] [Revised: 10/08/2011] [Accepted: 10/17/2011] [Indexed: 11/29/2022]
Abstract
BACKGROUND Whereas propionic acidemia (PA) is a target disease of newborn screening (NBS) in many countries, it is not in others. Data on the benefit of NBS for PA are sparse. STUDY DESIGN Twenty PA patients diagnosed through NBS were compared to 35 patients diagnosed by selective metabolic screening (SMS) prompted by clinical findings, family history, or routine laboratory test results. Clinical and biochemical data of patients from 16 metabolic centers in Germany, Austria, and Switzerland were evaluated retrospectively. Additionally, assessment of the intelligent quotient (IQ) was performed. In a second step, the number of PA patients who have died within the past 20 years was estimated based on information provided by the participating metabolic centers. RESULTS Patients diagnosed through NBS had neither a milder clinical course regarding the number of metabolic crises nor a better neurological outcome. Among NBS patients, 63% were already symptomatic at the time of diagnosis, and <10% of all patients remained asymptomatic. Among all PA patients, 76% were found to be at least mildly mentally retarded, with an IQ <69. IQ was negatively correlated with the number of metabolic decompensations, but not simply with the patients' age. Physical development was also impaired in the majority of patients. Mortality rates tended to be lower in NBS patients compared with patients diagnosed by SMS. CONCLUSION Early diagnosis of PA through NBS seems to be associated with a lower mortality rate. However, no significant benefit could be shown for surviving patients with regard to their clinical course, including the number of metabolic crises, physical and neurocognitive development, and long-term complications.
Collapse
Affiliation(s)
- S C Grünert
- Zentrum für Kinder- und Jugendmedizin, Universitätsklinikum Freiburg, Freiburg, Germany
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
144
|
Elixmann IM, Walter M, Kiefer M, Leonhardt S. Simulation of existing and future electromechanical shunt valves in combination with a model for brain fluid dynamics. Acta Neurochir Suppl 2012; 113:77-81. [PMID: 22116428 DOI: 10.1007/978-3-7091-0923-6_16] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/03/2022]
Abstract
Several models are available to simulate raised intracranial pressure (ICP) in hydrocephalus. However, the hydrodynamic effect of an implanted shunt has seldom been examined. In this study, the simple model of Ursino and Lodi [14]is extended to include (1) the effect of a typical ball-in-cone valve, (2) the effect of the size of the diameter of the connecting tube from valve to abdomen, and (3) the concept of a controlled electromechanical shunt valve in overall cerebrospinal fluid dynamics.By means of simulation, it is shown how a shunt can lower ICP. Simulation results indicate that P and B waves still exist but at a lower ICP level and that, due to the exponential pressure-volume curve, their amplitude is also considerably lowered. A waves only develop if the valve is partially blocked. The resulting ICP is above the opening pressure of the valve, depending on the drain and resistance of the shunt.The concept of a new electromechanical shunt was more successful than the traditional mechanical valves in keeping ICP at a desired level. The influence of the patient's movements or coughing on ICP as well as the body position affecting the reference ICP, which can be measured, has not yet been modeled and should be addressed in future using suitable algorithms.
Collapse
Affiliation(s)
- Inga Margrit Elixmann
- Helmholtz-Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany.
| | | | | | | |
Collapse
|
145
|
Kraus JP, Spector E, Venezia S, Estes P, Chiang PW, Creadon-Swindell G, Müllerleile S, de Silva L, Barth M, Walter M, Walter K, Meissner T, Lindner M, Ensenauer R, Santer R, Bodamer OA, Baumgartner MR, Brunner-Krainz M, Karall D, Haase C, Knerr I, Marquardt T, Hennermann JB, Steinfeld R, Beblo S, Koch HG, Konstantopoulou V, Scholl-Bürgi S, van Teeffelen-Heithoff A, Suormala T, Ugarte M, Sperl W, Superti-Furga A, Schwab KO, Grünert SC, Sass JO. Mutation analysis in 54 propionic acidemia patients. J Inherit Metab Dis 2012; 35:51-63. [PMID: 22033733 DOI: 10.1007/s10545-011-9399-0] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/23/2011] [Revised: 07/20/2011] [Accepted: 09/15/2011] [Indexed: 10/15/2022]
Abstract
Deficiency of propionyl CoA carboxylase (PCC), a dodecamer of alpha and beta subunits, causes inherited propionic acidemia. We have studied, at the molecular level, PCC in 54 patients from 48 families comprised of 96 independent alleles. These patients of various ethnic backgrounds came from research centers and hospitals in Germany, Austria and Switzerland. The thorough clinical characterization of these patients was described in the accompanying paper (Grünert et al. 2012). In all 54 patients, many of whom originated from consanguineous families, the entire PCCB gene was examined by genomic DNA sequencing and in 39 individuals the PCCA gene was also studied. In three patients we found mutations in both PCC genes. In addition, in many patients RT-PCR analysis of lymphoblast RNA, lymphoblast enzyme assays, and expression of new mutations in E.coli were carried out. Eight new and eight previously detected mutations were identified in the PCCA gene while 15 new and 13 previously detected mutations were found in the PCCB gene. One missense mutation, p.V288I in the PCCB gene, when expressed in E.coli, yielded 134% of control activity and was consequently classified as a polymorphism in the coding region. Numerous new intronic polymorphisms in both PCC genes were identified. This study adds a considerable amount of new molecular data to the studies of this disease.
Collapse
Affiliation(s)
- J P Kraus
- Department of Pediatrics, Colorado Intellectual and Developmental Disabilities Research Center (IDDRC), University of Colorado Denver, Anschutz Medical Campus, Aurora, CO 80045, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
146
|
Loret C, Walter M, Pineau N, Peyron M, Hartmann C, Martin N. Physical and related sensory properties of a swallowable bolus. Physiol Behav 2011; 104:855-64. [DOI: 10.1016/j.physbeh.2011.05.014] [Citation(s) in RCA: 69] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2010] [Revised: 05/06/2011] [Accepted: 05/10/2011] [Indexed: 11/26/2022]
|
147
|
Grimm S, Scheidegger M, Henning A, Walter M, Weigand A, Böker H, Bajbouj M, Seifritz E. Emotionalcognitive processing and brain metabolism after pharmacological challenge with ketamine. Pharmacopsychiatry 2011. [DOI: 10.1055/s-0031-1292482] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
148
|
Scheidegger M, Henning A, Walter M, Fuchs A, Krähenmann R, Böker H, Bösiger P, Seifritz E, Grimm S. Acute ketamine administration modulates glutamatergic neurotransmission and functional brain activation in prefrontal cortex implications for major depression. Pharmacopsychiatry 2011. [DOI: 10.1055/s-0031-1292539] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
149
|
Meister L, Alawam K, Dudley E, Taurines R, Müller SE, Walter M, Höppner J, Teipel S, Donev RM, Eckert A, Wiesbeck GA, Thome J. Pilot study of the application of magnetic bead protein profiling to the study of biomarkers in addiction research. World J Biol Psychiatry 2011; 12 Suppl 1:80-4. [PMID: 21906001 DOI: 10.3109/15622975.2011.598712] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
OBJECTIVES Proteomic technologies based on mass spectrometry are increasingly used as a valuable tool in clinical research allowing high-throughput protein and peptide profiling to be undertaken. Whilst previous research has focussed the application of this novel technology on the study of patients with disorders compared to comparable individuals from the healthy population, this current study seeks to determine the effect of successful treatment for alcoholism on the serum protein profile obtained. METHODS Serum samples were collected from patients after initial treatment for alcohol abuse and also 6 months after treatment. The serum samples were prepared for analysis using reverse phase magnetic bead fractionation and the resulting peptides analysed by matrix assisted laser desorption ionisation time-of-flight (MALDI-ToF) mass spectrometry. RESULTS Whilst the majority of the peptides detected by this approach exhibited constant levels between the two time points, three peptides were elevated at the 6-month time point compared to the initial sampling. CONCLUSIONS Whilst disorders with very clear biological causes (such as cancer) exhibit significantly different peptide profiles, psychiatric disorders such as alcohol addiction which are multifactorial show less obvious changes. Despite this the two groups of samples could statistically be distinguished by certain peptides expression levels.
Collapse
Affiliation(s)
- L Meister
- Division of Substance Use Disorders, Psychiatric Hospital of University of Basel, Basel, Switzerland
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
150
|
Walter M. Structure and electronic properties of free, supported and protected clusters. Acta Crystallogr A 2011. [DOI: 10.1107/s0108767311095821] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|